Preclinical Models from Pharmacology Discovery Services
|Anti-Infectives/Microbiology||Inflammation/Allergy||Cardiovascular||CNS / Pain|
Trust the experts at our Partner Lab, Pharmacology Discovery Services, with the preclinical assessment of your most promising candidates
Our Partner Lab, Pharmacology Discovery Services, has a long and successful history of creating and testing models to evaluate the pharmacological effects of drug candidates in all major therapeutic categories with emphasis on anti-infectives, inflammation/allergy, CNS/pain and oncology.
Their portfolio provides progressive evaluation of your study from tolerability and exposure through all levels of pharmacodynamics, including primary screening for activity and rank-ordering, lead identification, candidate selection, disease-specific efficacy and dose-dependent proof-of-concept in relevant translational studies.
They provide therapeutically focused disease models, incorporating biomarkers and outcome measures that enable greater prediction of clinical success. All in vivo studies are supported by a dedicated team of global Technical Directors specializing in specific therapeutic areas. The scientific experts at Pharmacology Discovery Services, with their years of pharmaceutical drug development expertise, provide you ongoing project oversight, with prompt communication and a commitment to on-time reporting, enabling you to meet your strict drug-development timelines.
The expert laboratory staff can formulate and dose test articles by virtually any route, including short- or long-term continuous infusion, and can monitor blood, brain, tissue and/or CSF exposure for PK/PD studies, as well as conduct biomarker analyses. Technical and Study Directors are readily available for consultations, allowing custom study designs to meet your budgetary needs.
Advantages of in vivo testing with our Partner Lab, Pharmacology Discovery Services: